Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vitamin E and muscle diseases.

M J Jackson, D A Jones, R H Edwards

    Journal of Inherited Metabolic Disease
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Vitamin E, an antioxidant, may reduce muscle damage in severe myopathies. This approach is suggested when specific calcium antagonists or phospholipase inhibitors are unavailable for skeletal muscle treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Waterloo Differential Acuity Test (WatDAT)-Testability and normative data.

    Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)·2025
    Same author

    Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin Lymphoma.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2023
    Same author

    Discharge after primary percutaneous coronary intervention: the earlier the better?

    European heart journal. Quality of care & clinical outcomes·2021
    Same author

    Use of enhanced stent visualisation compared to angiography alone to guide percutaneous coronary intervention.

    International journal of cardiology·2020
    Same author

    The Noncanonical Pathway for In Vivo Nitric Oxide Generation: The Nitrate-Nitrite-Nitric Oxide Pathway.

    Pharmacological reviews·2020
    Same author

    Long-Term Endurance and Power Training May Facilitate Motor Unit Size Expansion to Compensate for Declining Motor Unit Numbers in Older Age.

    Frontiers in physiology·2019
    Same journal

    Beyond Upper Airway Involvement: Evidence of Intrinsic Lung Disease in a Mouse Model of Mucopolysaccharidosis I.

    Journal of inherited metabolic disease·2026
    Same journal

    Immune Dysregulation in Branched Chain Organic Acidemias.

    Journal of inherited metabolic disease·2026
    Same journal

    Long Term Follow-Up After Transplantation in Propionic Acidemia: A Retrospective French Pediatric and Adult Cohort Study.

    Journal of inherited metabolic disease·2026
    Same journal

    Tri-Parametric Assessment of α-Galactosidase A Activity, lysoGb3 and X-Inactivation Aids Genotype-Phenotype Categorization of Fabry Disease Female Patients.

    Journal of inherited metabolic disease·2026
    Same journal

    Mapping the Severity of Phenylalanine Hydroxylase Deficiency.

    Journal of inherited metabolic disease·2026
    Same journal

    Gaucher Disease Treated With Lentiviral-Mediated Gene Therapy: First Case.

    Journal of inherited metabolic disease·2026
    See all related articles

    Area of Science:

    • Biochemistry
    • Muscle Physiology
    • Pharmacology

    Background:

    • Muscle damage in severe myopathies like muscular dystrophy is a significant concern.
    • Research focuses on biochemical mechanisms to identify protective agents.
    • Three classes of agents show potential: calcium antagonists, phospholipase inhibitors, and antioxidants.

    Purpose of the Study:

    • To investigate the potential of antioxidants, specifically Vitamin E, in mitigating muscle damage.
    • To explore therapeutic strategies for severe myopathies in the absence of specific pharmacological agents.

    Main Methods:

    • Review of studies on biochemical mechanisms of muscle damage.
    • Evaluation of Vitamin E's efficacy in reducing damage in isolated skeletal muscles under stress.

    Related Experiment Videos

    Main Results:

    • Vitamin E, an antioxidant, demonstrated a reduction in muscle damage in isolated skeletal muscle models.
    • The study identified antioxidants as a promising therapeutic category.

    Conclusions:

    • Vitamin E and other antioxidants may be beneficial in reducing muscle damage in patients with severe myopathies.
    • This therapeutic avenue is particularly relevant when specific calcium antagonists or phospholipase inhibitors are not suitable for human skeletal muscle.